title: Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.
authors.affiliation: Department of Internal Medicine 1, Oita University, Oita, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Kume
authors.forename: Naohiko
authors.initials: N
authors.lastname: Takahashi
authors.forename: Osamu
authors.initials: O
authors.lastname: Wakisaka
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Nagano-Torigoe
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Teshima
authors.forename: Mikiko
authors.initials: M
authors.lastname: Nakagawa
authors.forename: Kunio
authors.initials: K
authors.lastname: Yufu
authors.forename: Masahide
authors.initials: M
authors.lastname: Hara
authors.forename: Tetsunori
authors.initials: T
authors.lastname: Saikawa
authors.forename: Hironobu
authors.initials: H
authors.lastname: Yoshimatsu
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000517:prevention & control*; D015153:Blotting, Western; D004195:Disease Models, Animal; D004452:Echocardiography; D005355:Fibrosis / Q000188:drug therapy* / Q000473:pathology; D006325:Heart Atria / Q000187:drug effects* / Q000473:pathology*; D007249:Inflammation / Q000473:pathology / Q000517:prevention & control; D018836:Inflammation Mediators / Q000032:analysis; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000032:analysis; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000473:pathology; D000077205:Pioglitazone; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D018836:Inflammation Mediators; D045162:Thiazolidinediones; D020780:Matrix Metalloproteinase 9; D000077205:Pioglitazone